Samantha Kirby

Samantha Kirby

Cooley LLP

Contact
View Bio
RSS

Latest Posts › Dismissals

Share:

In re Nektar Therapeutics: Ninth Circuit Affirms Dismissal of Securities Class Action Arising from Failure of Clinical Drug...

Summary - On May 19, 2022, a panel of the Ninth Circuit unanimously affirmed the district court’s dismissal of a putative securities fraud class action accusing Nektar Therapeutics and several of its executives of...more

6/8/2022  /  Class Action , Dismissals , Securities Exchange Act , Securities Fraud , Securities Litigation , Securities Violations
1 Results
 / 
View per page
Page: of 1

"My best business intelligence, in one easy email…"

Your first step to building a free, personalized, morning email brief covering pertinent authors and topics on JD Supra:
Sign up Log in
*By using the service, you signify your acceptance of JD Supra's Privacy Policy.
- hide
- hide